Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)

BACKGROUND: Asymptomatic carotid artery stenosis (ACS) can be treated with carotid endarterectomy (CEA), carotid artery stenting (CAS), or best medical treatment (BMT) only. For all treatment options, optimization of vascular risk factors such as arterial hypertension, hyperlipidemia, smoking, obesi...

Full description

Saved in:
Bibliographic Details
Main Authors: Reiff, Tilman (Author) , Eckstein, Hans-Henning (Author) , Mansmann, Ulrich (Author) , Jansen, Olav (Author) , Fraedrich, Gustav (Author) , Mudra, Harald (Author) , Hacke, Werner (Author) , Ringleb, Peter A. (Author)
Format: Article (Journal)
Language:English
Published: 19 October 2021
In: Neurological research and practice
Year: 2021, Volume: 3, Issue: 1, Pages: 1-10
ISSN:2524-3489
DOI:10.1186/s42466-021-00153-w
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s42466-021-00153-w
Get full text
Author Notes:Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, Olav Jansen, Gustav Fraedrich, Harald Mudra, Werner Hacke and Peter Arthur Ringleb for the SPACE-2 study group

MARC

LEADER 00000caa a2200000 c 4500
001 1777106923
003 DE-627
005 20240414193545.0
007 cr uuu---uuuuu
008 211110s2021 xx |||||o 00| ||eng c
024 7 |a 10.1186/s42466-021-00153-w  |2 doi 
035 |a (DE-627)1777106923 
035 |a (DE-599)KXP1777106923 
035 |a (OCoLC)1341423849 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Reiff, Tilman  |e VerfasserIn  |0 (DE-588)1062797728  |0 (DE-627)806943742  |0 (DE-576)420213643  |4 aut 
245 1 0 |a Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)  |c Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, Olav Jansen, Gustav Fraedrich, Harald Mudra, Werner Hacke and Peter Arthur Ringleb for the SPACE-2 study group 
264 1 |c 19 October 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.11.2021 
520 |a BACKGROUND: Asymptomatic carotid artery stenosis (ACS) can be treated with carotid endarterectomy (CEA), carotid artery stenting (CAS), or best medical treatment (BMT) only. For all treatment options, optimization of vascular risk factors such as arterial hypertension, hyperlipidemia, smoking, obesity, and insufficient physical activity is essential. Data on adherence to BMT and lifestyle modification in patients with ACS are sparse. The subject of this investigation is the implementation and quality of risk factor adjustment in the context of a randomized controlled trial. METHODS: A total of 513 patients in the prematurely terminated, randomized, controlled, multicenter SPACE-2 trial (ISRCTN 78592017) were analyzed within one year after randomization into 3 groups (CEA, CAS, and BMT only) for implementation of prespecified BMT recommendations and lifestyle modifications. Measurement time points were the screening visit and visits after one month (D30), 6 months (M6), and one year (A1). Differences between groups and follow-up visits (FUVs) relative to the screening visit were investigated. FINDINGS: For all FUVs, a significant increase in statin medication (91% at A1; p < 0.0001) was demonstrated to be associated with a significant decrease (p < 0.01) in cholesterol levels (median 167 mg/dl at A1) and LDL cholesterol levels (median 93 mg/dl at A1). The lowest cholesterol levels were achieved by patients in the BMT group. Seventy-eight percent of all patients reached predefined target cholesterol levels (< 200 mg/dl), with significantly better rates in the BMT group (p = 0.036 at D30). Furthermore, a significant decrease in arterial blood pressure at all FUVs (p < 0.05) was associated with a significant increase in antihypertensive medication (96% at A1, p < 0.0001). However, only 28% of patients achieved the predefined treatment goal of a systolic blood pressure of ≤ 130 mmHg. Forty-two of a total of 100 smokers at the screening visit quit smoking within one year, resulting in a significant increase in nonsmokers at all FUVs (p < 0.0001). Recommended HbA1c levels (< 7%) were achieved in 82% without significant changes after one year. Only 7% of obese (BMI > 25) patients achieved sufficient weight reduction after one year without significant changes at all FUVs (median BMI 27 at A1; p = 0.1201). The BMT group showed significantly (p = 0.024) higher rates of adequate physical activity than the intervention groups. Furthermore, after one year, the BMT group showed a comparatively significantly better implementation of risk factor modification (77%; p = 0.027) according to the treating physician. INTERPRETATION: SPACE-2 demonstrated sustained improvement in the noninterventional management of vascular risk factors in patients treated in a clinical trial by general practitioners, internists and neurologists. The best implemented treatment targets were a reduction in cholesterol and HbA1c levels. In this context, a significant increase in statin use was demonstrated. Blood pressure control missed its target but was significantly reduced by intensification of antihypertensive medication. Patients on BMT only had better adjusted lipid parameters and were more physically active. However, all groups failed to achieve sufficient weight reduction. Due to insufficient patient recruitment, the results must be interpreted cautiously. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN78592017, Registered 16 June 2007, https://www.isrctn.com/search?q=78592017 . 
650 4 |a Asymptomatic carotid artery stenosis 
650 4 |a Best medical treatment 
650 4 |a Carotid artery stenting 
650 4 |a Carotid endarterectomy 
650 4 |a Disease-free survival 
650 4 |a Epidemiology 
650 4 |a Primary prevention 
650 4 |a Prospective study 
700 1 |a Eckstein, Hans-Henning  |d 1955-2024  |e VerfasserIn  |0 (DE-588)1062633598  |0 (DE-627)805602844  |0 (DE-576)419993576  |4 aut 
700 1 |a Mansmann, Ulrich  |e VerfasserIn  |0 (DE-588)1047558459  |0 (DE-627)778551792  |0 (DE-576)401157695  |4 aut 
700 1 |a Jansen, Olav  |e VerfasserIn  |0 (DE-588)111617413  |0 (DE-627)581090209  |0 (DE-576)289707765  |4 aut 
700 1 |a Fraedrich, Gustav  |e VerfasserIn  |4 aut 
700 1 |a Mudra, Harald  |e VerfasserIn  |4 aut 
700 1 |a Hacke, Werner  |d 1948-  |e VerfasserIn  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 aut 
700 1 |a Ringleb, Peter A.  |e VerfasserIn  |0 (DE-588)1032676175  |0 (DE-627)73863364X  |0 (DE-576)172917743  |4 aut 
773 0 8 |i Enthalten in  |t Neurological research and practice  |d [London] : BioMed Central, 2019  |g 3(2021), 1, Artikel-ID 62, Seite 1-10  |h Online-Ressource  |w (DE-627)1038162947  |w (DE-600)2947493-0  |w (DE-576)512479968  |x 2524-3489  |7 nnas  |a Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2) 
773 1 8 |g volume:3  |g year:2021  |g number:1  |g elocationid:62  |g pages:1-10  |g extent:10  |a Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2) 
856 4 0 |u https://doi.org/10.1186/s42466-021-00153-w  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211110 
993 |a Article 
994 |a 2021 
998 |g 1032676175  |a Ringleb, Peter A.  |m 1032676175:Ringleb, Peter A.  |d 910000  |d 911100  |e 910000PR1032676175  |e 911100PR1032676175  |k 0/910000/  |k 1/910000/911100/  |p 8  |y j 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 50000  |e 50000PH12021699X  |k 0/50000/  |p 7 
998 |g 111617413  |a Jansen, Olav  |m 111617413:Jansen, Olav  |p 4 
998 |g 1047558459  |a Mansmann, Ulrich  |m 1047558459:Mansmann, Ulrich  |p 3 
998 |g 1062633598  |a Eckstein, Hans-Henning  |m 1062633598:Eckstein, Hans-Henning  |p 2 
998 |g 1062797728  |a Reiff, Tilman  |m 1062797728:Reiff, Tilman  |d 910000  |d 911100  |e 910000PR1062797728  |e 911100PR1062797728  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1777106923  |e 4001051346 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1777106923","title":[{"title":"Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)","title_sort":"Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)"}],"name":{"displayForm":["Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, Olav Jansen, Gustav Fraedrich, Harald Mudra, Werner Hacke and Peter Arthur Ringleb for the SPACE-2 study group"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"person":[{"roleDisplay":"VerfasserIn","family":"Reiff","role":"aut","display":"Reiff, Tilman","given":"Tilman"},{"roleDisplay":"VerfasserIn","family":"Eckstein","display":"Eckstein, Hans-Henning","role":"aut","given":"Hans-Henning"},{"roleDisplay":"VerfasserIn","family":"Mansmann","given":"Ulrich","display":"Mansmann, Ulrich","role":"aut"},{"given":"Olav","display":"Jansen, Olav","role":"aut","family":"Jansen","roleDisplay":"VerfasserIn"},{"given":"Gustav","role":"aut","display":"Fraedrich, Gustav","family":"Fraedrich","roleDisplay":"VerfasserIn"},{"given":"Harald","role":"aut","display":"Mudra, Harald","roleDisplay":"VerfasserIn","family":"Mudra"},{"family":"Hacke","roleDisplay":"VerfasserIn","given":"Werner","display":"Hacke, Werner","role":"aut"},{"family":"Ringleb","roleDisplay":"VerfasserIn","given":"Peter A.","display":"Ringleb, Peter A.","role":"aut"}],"note":["Gesehen am 10.11.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"19 October 2021"}],"relHost":[{"title":[{"title":"Neurological research and practice","title_sort":"Neurological research and practice","subtitle":"official journal of the German Neurological Society"}],"disp":"Successful implementation of best medical treatment for patients with asymptomatic carotid artery stenosis within a randomized controlled trial (SPACE-2)Neurological research and practice","recId":"1038162947","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"isb","display":"Deutsche Gesellschaft für Neurologie","roleDisplay":"Herausgebendes Organ"}],"pubHistory":["Volume 1, issue 1 (December 2019)-"],"part":{"text":"3(2021), 1, Artikel-ID 62, Seite 1-10","pages":"1-10","year":"2021","volume":"3","issue":"1","extent":"10"},"note":["Gesehen am 25. März 2019"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["1038162947"],"issn":["2524-3489"],"zdb":["2947493-0"]},"origin":[{"publisher":"BioMed Central","dateIssuedDisp":"[2019]-","publisherPlace":"[London]"}]}],"id":{"eki":["1777106923"],"doi":["10.1186/s42466-021-00153-w"]}} 
SRT |a REIFFTILMASUCCESSFUL1920